DrugSafety Quarterly is provided as a service to members from the ACR Drug Safety Committee, and is committed to providing news, insights and critical review of safety issues germane to anti-rheumatic therapy. Questions, comments and suggestions are always welcome. Please contact the editors at DSQ@rheumatology.org.
The information and views contained herein represent those of the DSQ authors/editors, and do not represent guidelines, official positions or statements from the ACR. The ACR is an independent professional medical and scientific society that does not guarantee, warrant or endorse any commercial product or service.